Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$35,000.00

Dendritic cell interactions with capsular polysaccharides from extracellular bacteria: impact on innate & adaptive immune responses

FY 2010-11

Summary
Infection often occurs when the immune system fails to respond optimally to invading pathogens, but exposing individuals to pathogen derived-components combined with an agent (called an adjuvant) that boosts immune responses is an effective strategy to generate robust immunity against infection. Therefore, the quest to manipulate the immune system to generate effective immunity against pathogens can be considered as the 'grand challenge' of modern immunology. An integral player orchestrating this immunity is a rare but widely distributed network of cells called dendritic cells (DC). DC, which have been called 'nature's adjuvants,' express pathogen recognition receptors to sense and respond to microbes or vaccines. Research in the last decade has shown a fundamental role for DC in initiating and controlling the quality and strength of the immune response. As such, DC represent attractive immune modulatory targets for vaccinologists and their critical role in controlling host immunity to intracellular pathogens is largely proved. However, much less is known regarding the role of DC in the immune response to extracellular bacteria, most of which are covered by a shell of sugars, known as the polysaccharide capsule (CPS), that help bacteria hide from the immune system. One such bacterium is Group B Streptococcus (GBS), a leading cause of disease and mortality in newborns in the Western hemisphere. Antibodies to CPS are crucial for protection against infection, although the nature of this response is under intense investigation. Fusion of CPS to a carrier protein enhances its ability to elicit an immune response; however, several important questions remain unsolved. In my research plan, I propose to delineate the interactions of GBS with DC to identify mechanisms by which DC can overcome the strategies used by encapsulated bacteria to evade the immune system and thus initiate a protective immune response. Data from these studies will provide new insights into the pathogenesis of the disease caused by encapsulated bacteria, thereby helping to advance the development of more potent anti-CPS vaccines. The efficacy of such vaccines will critically require optimal DC responses to generate a long-lasting, protective immunity.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
342150-2007
Name nom
Segura, Mariela
Department département
Pathologie et microbiologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2007
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5204
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Immunology
Research subject fr
Immunologie
Partie
4
Nb partie
5
Application title
Dendritic cell interactions with capsular polysaccharides from extracellular bacteria: impact on innate & adaptive immune responses
Keyword
NSERC
Application summary
Infection often occurs when the immune system fails to respond optimally to invading pathogens, but exposing individuals to pathogen derived-components combined with an agent (called an adjuvant) that boosts immune responses is an effective strategy to generate robust immunity against infection. Therefore, the quest to manipulate the immune system to generate effective immunity against pathogens can be considered as the 'grand challenge' of modern immunology. An integral player orchestrating this immunity is a rare but widely distributed network of cells called dendritic cells (DC). DC, which have been called 'nature's adjuvants,' express pathogen recognition receptors to sense and respond to microbes or vaccines. Research in the last decade has shown a fundamental role for DC in initiating and controlling the quality and strength of the immune response. As such, DC represent attractive immune modulatory targets for vaccinologists and their critical role in controlling host immunity to intracellular pathogens is largely proved. However, much less is known regarding the role of DC in the immune response to extracellular bacteria, most of which are covered by a shell of sugars, known as the polysaccharide capsule (CPS), that help bacteria hide from the immune system. One such bacterium is Group B Streptococcus (GBS), a leading cause of disease and mortality in newborns in the Western hemisphere. Antibodies to CPS are crucial for protection against infection, although the nature of this response is under intense investigation. Fusion of CPS to a carrier protein enhances its ability to elicit an immune response; however, several important questions remain unsolved. In my research plan, I propose to delineate the interactions of GBS with DC to identify mechanisms by which DC can overcome the strategies used by encapsulated bacteria to evade the immune system and thus initiate a protective immune response. Data from these studies will provide new insights into the pathogenesis of the disease caused by encapsulated bacteria, thereby helping to advance the development of more potent anti-CPS vaccines. The efficacy of such vaccines will critically require optimal DC responses to generate a long-lasting, protective immunity.